These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 30347838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

  • 3. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
    Rummel A.
    Curr Top Microbiol Immunol; 2013 May; 364():61-90. PubMed ID: 23239349
    [Abstract] [Full Text] [Related]

  • 4. Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.
    Yao G, Lam KH, Perry K, Weisemann J, Rummel A, Jin R.
    Toxins (Basel); 2017 Mar 08; 9(3):. PubMed ID: 28282873
    [Abstract] [Full Text] [Related]

  • 5. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    FEBS J; 2011 Dec 08; 278(23):4506-15. PubMed ID: 21624052
    [Abstract] [Full Text] [Related]

  • 6. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry.
    Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT.
    J Biol Chem; 2012 Nov 23; 287(48):40806-16. PubMed ID: 23027864
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co-receptor ganglioside.
    Gregory KS, Liu SM, Acharya KR.
    FEBS Open Bio; 2020 Mar 23; 10(3):298-305. PubMed ID: 31945264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX.
    Appl Microbiol Biotechnol; 2023 May 27; 107(10):3205-3216. PubMed ID: 37058230
    [Abstract] [Full Text] [Related]

  • 11. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 12. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
    Chai Q, Arndt JW, Dong M, Tepp WH, Johnson EA, Chapman ER, Stevens RC.
    Nature; 2006 Dec 21; 444(7122):1096-100. PubMed ID: 17167418
    [Abstract] [Full Text] [Related]

  • 13. Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.
    Kumaran D, Eswaramoorthy S, Furey W, Navaza J, Sax M, Swaminathan S.
    J Mol Biol; 2009 Feb 13; 386(1):233-45. PubMed ID: 19118561
    [Abstract] [Full Text] [Related]

  • 14. A Comprehensive Structural Analysis of Clostridium botulinum Neurotoxin A Cell-Binding Domain from Different Subtypes.
    Gregory KS, Acharya KR.
    Toxins (Basel); 2023 Jan 18; 15(2):. PubMed ID: 36828407
    [Abstract] [Full Text] [Related]

  • 15. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction.
    Rummel A, Mahrhold S, Bigalke H, Binz T.
    Mol Microbiol; 2004 Feb 18; 51(3):631-43. PubMed ID: 14731268
    [Abstract] [Full Text] [Related]

  • 16. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
    Baldwin MR, Barbieri JT.
    Toxicon; 2009 Oct 18; 54(5):570-4. PubMed ID: 19362106
    [Abstract] [Full Text] [Related]

  • 17. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
    Karalewitz AP, Kroken AR, Fu Z, Baldwin MR, Kim JJ, Barbieri JT.
    Biochemistry; 2010 Sep 21; 49(37):8117-26. PubMed ID: 20731382
    [Abstract] [Full Text] [Related]

  • 18. Crystal structure of the botulinum neurotoxin type G binding domain: insight into cell surface binding.
    Stenmark P, Dong M, Dupuy J, Chapman ER, Stevens RC.
    J Mol Biol; 2010 Apr 16; 397(5):1287-97. PubMed ID: 20219474
    [Abstract] [Full Text] [Related]

  • 19. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
    Kull S, Schulz KM, Weisemann J, Kirchner S, Schreiber T, Bollenbach A, Dabrowski PW, Nitsche A, Kalb SR, Dorner MB, Barr JR, Rummel A, Dorner BG.
    PLoS One; 2015 Apr 16; 10(2):e0116381. PubMed ID: 25658638
    [Abstract] [Full Text] [Related]

  • 20. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R, Rummel A, Binz T, Brunger AT.
    Nature; 2006 Dec 21; 444(7122):1092-5. PubMed ID: 17167421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.